Related Experiment Video
Updated: May 24, 2026
10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Cytokines in diabetic nephropathy.
Chia-Chao Wu1, Huey-Kang Sytwu, Yuh-Feng Lin
1Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Advances in Clinical Chemistry
|March 9, 2012
Summary
Diabetic nephropathy (DN) involves inflammation and immune responses, with cytokines playing a key role in its development. Understanding these cytokine pathways offers potential for new therapeutic strategies against this kidney disease.
Area of Science:
- Nephrology
- Immunology
- Endocrinology
Background:
- Diabetic nephropathy (DN) is a leading cause of end-stage renal disease (ESRD).
- DN is increasingly recognized as an inflammatory condition involving leukocyte infiltration in the kidneys.
- Inflammation and immune system activation are central to diabetes and its microvascular complications.
Purpose of the Study:
- To explore the role of cytokines in the pathogenesis and progression of diabetic nephropathy.
- To investigate the potential of targeting cytokine pathways for DN treatment.
Main Methods:
- Review of existing literature on cytokines and their involvement in DN.
- Analysis of the roles of various cytokines, including proinflammatory, Th1, Th2, Th17, and TGF-beta.
- Consideration of the impact of gene polymorphisms in cytokines and their receptors.
Main Results:
- Cytokines are critical mediators in the development and progression of DN.
- Specific cytokines (proinflammatory, Th1, Th2, Th17, TGF-beta) are implicated in DN pathogenesis.
- Gene variations in cytokines and receptors may influence DN susceptibility and progression.
Conclusions:
- Cytokines are significant pathogenic mediators in diabetic nephropathy.
- Targeting cytokine pathways presents a promising avenue for novel therapeutic interventions in DN.
- Further research into cytokine mechanisms can lead to improved treatments for DN.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...